SOL-GEL TECHN. IS-10 (F:4SG) — Market Cap & Net Worth
Market Cap & Net Worth: SOL-GEL TECHN. IS-10 (4SG)
SOL-GEL TECHN. IS-10 (F:4SG) has a market capitalization of $201.21 Million (€172.10 Million) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #16511 globally and #1570 in its home market, demonstrating a 8.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SOL-GEL TECHN. IS-10's stock price €61.50 by its total outstanding shares 3245270 (3.25 Million). Analyse 4SG cash flow metrics to see how efficiently the company converts income to cash.
SOL-GEL TECHN. IS-10 Market Cap History: 2019 to 2026
SOL-GEL TECHN. IS-10's market capitalization history from 2019 to 2026. Data shows growth from $42.87 Million to $233.33 Million (32.66% CAGR).
SOL-GEL TECHN. IS-10 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SOL-GEL TECHN. IS-10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
7.40x
SOL-GEL TECHN. IS-10's market cap is 7.40 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $21.82 Million | $31.27 Million | $3.22 Million | 0.70x | 6.77x |
| 2022 | $14.57 Million | $3.88 Million | -$14.92 Million | 3.75x | N/A |
| 2023 | $4.10 Million | $1.55 Million | -$27.24 Million | 2.64x | N/A |
| 2024 | $3.79 Million | $11.54 Million | -$10.58 Million | 0.33x | N/A |
| 2025 | $143.42 Million | $19.39 Million | -$6.13 Million | 7.40x | N/A |
Competitor Companies of 4SG by Market Capitalization
Companies near SOL-GEL TECHN. IS-10 in the global market cap rankings as of May 5, 2026.
Key companies related to SOL-GEL TECHN. IS-10 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
SOL-GEL TECHN. IS-10 Historical Marketcap From 2019 to 2026
Between 2019 and today, SOL-GEL TECHN. IS-10's market cap moved from $42.87 Million to $ 233.33 Million, with a yearly change of 32.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €233.33 Million | +62.70% |
| 2025 | €143.42 Million | +3680.00% |
| 2024 | €3.79 Million | -7.41% |
| 2023 | €4.10 Million | -71.88% |
| 2022 | €14.57 Million | -33.22% |
| 2021 | €21.82 Million | -26.28% |
| 2020 | €29.59 Million | -30.97% |
| 2019 | €42.87 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of SOL-GEL TECHN. IS-10 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $201.21 Million USD |
| MoneyControl | $201.21 Million USD |
| MarketWatch | $201.21 Million USD |
| marketcap.company | $201.21 Million USD |
| Reuters | $201.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SOL-GEL TECHN. IS-10
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treat… Read more